Tuesday, March 15, 2011

Darvocet Lawyers Assist Plaintiffs with Settlements

Darvocet was pulled from the market in the United States and Canada in November of 2010, and since then many lawsuits have been filed against the drugmaker Xanodyne regarding Darvon and Darvocet side effects. Xanodyne is expected to eventually pay a total of several million – maybe even a few billion – dollars in settlements to plaintiffs complaining of various severe side effects often associated with the medication.
Although no Darvocet settlements have yet been reached and no verdicts have been obtained in Darvocet jury trials, similar cases involving other drugs with significant side effects have sometimes netted plaintiffs millions of dollars – in the case of one Alabama man, his compensation for side effects suffered as a result of taking the acne drug Accutane was $25 million. These huge sums could be reflected in settlements with Xanodyne, since large pharmaceuticals companies such as this often have the means to give plaintiffs a higher payoff.

A victim of Darvocet side effects

Although many plaintiffs who have already filed suit against Xanodyne remain anonymous, Kristin Esposito has filed her lawsuit against the company publicly. She was diagnosed with a heart arrhythmia and is seeking compensation for lost earnings as well as past and future medical bills. She is asking for $10 million – which is not unreasonable, considering the severity of the side effects sometimes associated with Darvon, Darvocet, and other propoxyphene products. Many plaintiffs can expect to receive similar amounts, depending on the severity of their specific side effect and whether they have lost significant wages or large amounts of their own money through medical bills.
Because many times, during a trial by jury, the plaintiff is awarded more than he or she would have been if a settlement had been reached, it is possible that Xanodyne will choose to settle with plaintiffs instead of allowing each case to go to trial. Either way, this decision is likely to be favorable for the plaintiff.

No comments:

Post a Comment